Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Kim, Ji Yoon ^a   Yoo, Eun Jung ^a   Jang, Jeong Won ^a   Kwon, Jung Hyun ^a   Kim, Ki Jun ^a   Kay, Chul Seung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Helical tomotherapy; Hepatocellular carcinoma; Portal vein tumor thrombosis

Indexed keywords

CAPECITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PORTAL VEIN TUMOR THROMBOSIS; PREDICTION; RADIATION DOSE FRACTIONATION; SCORING SYSTEM; SURVIVAL RATE; THERAPY EFFECT; TOMOTHERAPY; TREATMENT RESPONSE; TUMOR THROMBUS;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 84872198447     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-15     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca 2005, 55:74-108.
2. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, Monden M, Kudo M. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007, 37:676-691. 10.1111/j.1872-034X.2007.00119.x, 17617112.
3. Pirisi M, Avellini C, Fabris C, Scott C, Bardus P, Soardo G, Beltrami CA, Bartoli E. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 1998, 124:397-400. 10.1007/s004320050189, 9719503.
4. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996, 77:2217-2222. 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M, 8635087.
5. Park KW, Park J, Choi JI, Kim TH, Kim SH, Park HS, Lee WJ, Park SJ, Hong EK, Kim C. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2008, 23:467-473. 10.1111/j.1440-1746.2007.05112.x, 17764529.
6. Han K, Seong J, Kim JK, Ahn SH, Lee DY, Chon CY. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008, 113:995-1003. 10.1002/cncr.23684, 18615601.
7. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995, 31:1237-1248. 10.1016/0360-3016(94)00418-K, 7713785.
8. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346. 10.1016/0360-3016(95)00060-C, 7713792.
9. Mornex F, Girard N, Beziat C, Kubas A, Khodri M, Trepo C, Merle P. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006, 66:1152-1158. 10.1016/j.ijrobp.2006.06.015, 17145534.
10. Toya R, Murakami R, Baba Y, Nishimura R, Morishita S, Ikeda O, Kawanaka K, Beppu T, Sugiyama S, Sakamoto T, Yamashita Y, Oya N. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncology 2007, 84:266-271.
11. Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, Kho KC, Kim TH, Ahn YC, Huh SJ. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005, 103:2419-2426. 10.1002/cncr.21043, 15822130.
12. Jang JW, Kay CS, You CR, Kim CW, Bae SH, Choi JY, Yoon SK, Han CW, Jung HS, Choi IB. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys 2009, 74:412-418. 10.1016/j.ijrobp.2008.08.034, 18963538.
13. Kim JY, Kay CS, Kim YS, Jang JW, Bae SH, Choi JY, Yoon SK, Kim KJ. Helical tomotherapy for simultaneous multitarget radiotherapy for pulmonary metastasis. Int J Radiat Oncol Biol Phys 2009, 75:703-710. 10.1016/j.ijrobp.2008.11.065, 19419818.
14. McIntosh A, Hagspiel KD, Al Osaimi AM, Northup P, Caldwell S, Berg C, Angle JF, Argo C, Weiss G, Rich TA. Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. Cancer 2009, 115:5117-5125. 10.1002/cncr.24552, 19642177.
15. Choi BO, Choi IB, Jang HS, Kang YN, Jang JS, Bae SH, Yoon SK, Chai GY, Kang KM. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 2008, 8:351. 10.1186/1471-2407-8-351, 2615783, 19038025.
16. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003, 38:207-215. 10.1007/s005350300038, 12673442.
17. Kim TH, Kim DY, Park J, Kim SH, Choi J, Kim HB, Lee WJ, Park SJ, Hong EK, Kim C. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:225-231. 10.1016/j.ijrobp.2006.08.015, 17056199.
18. Cheng JC, Wu J, Huang C, Liu H, Huang DY, Cheng SH, Tsai SY, Jian JJ, Lin Y, Cheng TI, Horng C, Huang AT. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 2002, 54:156-162.
19. Cheng JC, Wu JK, Huang C, Liu H, Huang DY, Tsai SY, Cheng SH, Jian JJ, Huang AT. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2003, 56:229-234. 10.1016/S0360-3016(03)00091-9, 12694843.
20. Lee IJ, Seong J, Koom WS, Kim YB, Jeon BC, Kim JH, Han KH. Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma. Jpn J Clinic Oncol 2011, 41:447-454.